Showing results (181-190 of 524) with videos related to
Sort By:
Pageof 53
Therapeutic Advances in Vaccines and Immunotherapy|August 29, 2022
Improving health literacy with mumps, measles and rubella (MMR) vaccination: comparison of the readability of MMR patient-facing literature and MMR scientific abstractsTina Downey, Beverley C Millar, John E MooreInvestigative Ophthalmology & Visual Science|November 1, 1995
Prostaglandin F2 alpha effects on isolated rhesus monkey ciliary muscleJ F Poyer, C Millar, P L KaufmanIEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|February 2, 2008
PVDF reference hydrophone development in the UK-from fabrication and lamination to use as secondary standardsS Robinson, R Preston, M Smith, et al.British Journal of Biomedical Science|November 6, 2024
Improving Biomedical Science Literacy and Patient-Directed Knowledge of Tuberculosis (TB): A Cross-Sectional Infodemiology Study Examining Readability of Patient-Facing TB InformationCaoimhe Shannon, Beverley C Millar, John E MooreContemporary Clinical Trials|November 8, 2022
Using plain language to communicate with clinical trials participants: Comparison of readability calculatorsLauren McGrath, Beverley C Millar, John E MooreIntensive Care Medicine|April 1, 1996
Bladder epithelial oxygen tension--a new means of monitoring regional perfusion? Preliminary study in a model of exsanguination/fluid repletionM Singer, C Millar, R Stidwill, et al.The Biochemical Journal|December 15, 1987
A transient kinetic study of enthalpy changes during the reaction of myosin subfragment 1 with ATPN C Millar, J V Howarth, H GutfreundTranslational Andrology and Urology|April 14, 2021
Genetics of hypogonadotropic hypogonadismAdam C Millar, Hanna Faghfoury, Jared M BieniekJournal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 5, 2001
Intraocular pressure and vascular effects of sodium azide in bovine perfused eyeJ C Millar, M Shahidullah, W S WilsonBritish Journal of Cancer|November 1, 1981
Flurbiprofen, a non-steroid anti-inflammatory agent, protects cells against hypoxic cell radiosensitizers in vitroB C Millar, S Jinks, T J PowlesPageof 53